Qiyun Tang

5PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K/AKT/mTOR signaling mediated by SLFN5.

|Apr 21, 2026
HMGCS1 as a potential mediator of resistance to EZH2 inhibition via ferroptosis mediated by PI3K/AKT/mTOR pathway in the pancreatic neuroendocrine neoplasms.

|Nov 11, 2024
Hypoxia drives CBR4 down-regulation promotes gastroenteropancreatic neuroendocrine tumors via activation mammalian target of rapamycin mediated by fatty acid synthase.

Mujie Ye, Lin Xu, Feiyu Lu

|Jun 26, 2024
Hypoxia exosome derived CEACAM5 promotes tumor-associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9.

Mujie Ye, Feiyu Lu, Danyang Gu

|Oct 01, 2021
A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer.

Jiahang Song, Shuming Zhang, Yuanyuan Sun

Pageof 1

Frequent Collaborators

2 joint publications

Mujie Ye

2 joint publications

Jianan Bai

1 joint publications

Jiahang Song

1 joint publications

Shuming Zhang